Nigeria In-Vitro Diagnostics (IVD) Market Research Report: Forecast (2026-2032)

Nigeria In-Vitro Diagnostics (IVD) Market - By Product Type (Reagents & Kits, Instruments, Consumables, Software & Services) By Technology– (Immunoassays, Molecular Diagnostics, Clinical Chemi... ... stics, Clinical Chemistry, Microbiological Diagnostics, Hematologic Diagnostics, Coagulation, Others), By Distribution Channel (Direct Tender, Retail Pharmacy Chains, Online Distribution Platforms, Third-Party Distributors & Wholesalers), By End User (Hospitals & Clinics, Diagnostic Laboratories, Blood Banks, Point-of-Care Testing Centers, Research Institutes & Academic Settings, Others (e.g., mobile clinics, community health centers), By Application (Infectious Diseases, Malaria, HIV/AIDS, Tuberculosis, Hepatitis B & C, Lassa Fever, Others (Diphtheria), Chronic Diseases, Diabetes, Cardiovascular Diseases, Oncology, Nephrology, Others), and others Read more

  • Healthcare
  • Dec 2025
  • 135
  • PDF, Excel, PPT

Nigeria In-Vitro Diagnostics (IVD) Market Size: Forecast (2026-2032)

The Nigeria In-Vitro Diagnostics (IVD) Market size is valued at around USD41.29 million in 2025 and is projected to reach USD79.92 million by 2032. Along with this, the market is estimated to grow at a CAGR of around 9.89% during the forecast period, i.e., 2026-32.

Nigeria In-Vitro Diagnostics (IVD) Market Outlook:

Nigeria’s IVD Market is strengthening rapidly as the country responds to some of the most severe disease burdens in Africa. Nigeria accounts for over a quarter of global malaria cases (WHO), faces hundreds of thousands of tuberculosis infections every year, and continues to manage widespread HIV, Lassa fever, and diphtheria outbreaks, with significant Lassa fever activity reported nationwide in 2025 and diphtheria affecting thousands of citizens across multiple states since 2023 (NCDC, WHO). These high and persistent burdens create continuous demand for timely diagnostics across hospitals, clinics, and public-health programs.

Additionally, government programmes are also widening access to critical diagnostic services. Under Nigeria’s HIV programme, millions of people are screened annually for HIV, while the National Blood Service Commission (NBSC) conducts safety testing for over 500,000 donated blood units every year, each requiring mandatory screening for HIV, HBV, HCV, and syphilis.

Likewise, Nigeria’s Malaria Elimination Plan 2021–2025 aims to reduce malaria prevalence below 10%, prompting nationwide scale-up of rapid tests, microscopy, and surveillance diagnostics. This commitment strengthens demand for IVD kits and supports continuous investment in laboratory and community-level testing. These initiatives generate great, predictable demand for rapid tests, ELISA kits, molecular reagents, and laboratory consumables.

Moreover, investments are visible on the infrastructure side as well. The Nigeria Sovereign Investment Authority (NSIA), through its Healthcare Development and Investment Company, is funding 23 state-of-the-art diagnostic and oncology centres across the country. The Federal Government’s Basic Healthcare Provision Fund also allocated billions of naira to strengthen primary-care diagnostics, ensuring rural facilities gain access to essential testing equipment.

Nigeria In-Vitro Diagnostics (IVD) Market Recent Developments:

  • 2025: Codix Bio opened Nigeria's first large-scale rapid diagnostic test (RDT) manufacturing plant in Ogun State. The facility is designed to produce millions of HIV, malaria, hepatitis, and other essential test kits, strengthening local diagnostic capacity and reducing reliance on imported supplies.
  • 2025: Roche Diagnostics established a new legal entity in Nigeria, strengthening its direct presence and commitment to expanding diagnostic access. The company aims to enhance the availability of molecular and tissue diagnostics, along with near-patient testing solutions across the country.

Nigeria In-Vitro Diagnostics (IVD) Market Scope:

 Category  Segments
By Product Type Reagents & Kits, Instruments, Consumables, Software & Services)
By Technology Immunoassays, Molecular Diagnostics, Clinical Chemistry, Microbiological Diagnostics, Hematologic Diagnostics, Coagulation, Others),
By Distribution Channel Direct Tender, Retail Pharmacy Chains, Online Distribution Platforms, Third-Party Distributors & Wholesalers),
By End User Hospitals & Clinics, Diagnostic Laboratories, Blood Banks, Point-of-Care Testing Centers, Research Institutes & Academic Settings, Others (e.g., mobile clinics, community health centers),
By Application Infectious Diseases, Malaria, HIV/AIDS, Tuberculosis, Hepatitis B & C, Lassa Fever, Others (Diphtheria), Chronic Diseases, Diabetes, Cardiovascular Diseases, Oncology, Nephrology, Others), and others

Nigeria In-Vitro Diagnostics (IVD) Market Drivers:

Rising Cases of Infectious Diseases Accelerating Diagnostic Demand

Nigeria’s heavy infectious-disease burden remains one of the strongest forces driving growth in this market, as widespread and recurring illnesses create continuous demand for reagents, rapid test kits, and laboratory consumables. According to the World Health Organization, Nigeria accounts for about 27% of global malaria cases, leading to tens of millions of suspected cases each year, each requiring rapid testing or microscopy.

Beyond malaria, the prevalence of other infectious diseases reinforces high diagnostic volume. For instance, Nigeria recorded an estimated 460,000 tuberculosis (TB) cases in 2023, placing it among the world’s high-burden countries. In addition, the Nigeria Centre for Disease Control reported 758 confirmed Lassa fever cases with 143 deaths in 2025, highlighting a significant outbreak across 18 states. Nigeria also experienced one of its largest diphtheria outbreaks in recent history, with 557 confirmed cases across 21 states and the FCT since 2023 (WHO). These outbreaks require rapid testing, PCR confirmation, and repeated surveillance, increasing the use of molecular and serology-based diagnostics.

Moreover, HIV testing is also a major contributor to the country’s diagnostic workload. National HIV estimates indicate about 1.9 million people living with HIV in Nigeria as of 2025, and PEPFAR-supported programmes conduct millions of HIV screening and viral-load tests annually. This steady activity drives significant consumption of immunoassays, PCR reagents, and quality-control materials, particularly in high-volume hospitals and clinics.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Nigeria In-Vitro Diagnostics (IVD) Market Policies, Regulations, and Product Standards
  5. Nigeria In-Vitro Diagnostics (IVD) Market Supply Chain Analysis
  6. Nigeria In-Vitro Diagnostics (IVD) Market Trends & Developments
  7. Nigeria In-Vitro Diagnostics (IVD) Market Dynamics
    1. Growth Drivers
    2. Challenges
    3. Trends
    4. Opportunities
  8. Nigeria In-Vitro Diagnostics (IVD) Market Hotspot & Opportunities
  9. Nigeria In-Vitro Diagnostics (IVD) Market Pricing Analysis
  10. Nigeria In-Vitro Diagnostics (IVD) Market Strategic Insights
  11. Nigeria In-Vitro Diagnostics (IVD) Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Share & Outlook
      1. By Product Type– Market Size & Forecast 2022-2032, USD Million
        1. Reagents & Kits
        2. Instruments
        3. Consumables
        4. Software & Services
      2. By Technology– Market Size & Forecast 2022-2032, USD Million
        1. Immunoassays
        2. Molecular Diagnostics
        3. Clinical Chemistry
        4. Microbiological Diagnostics
        5. Hematologic Diagnostics
        6. Coagulation
        7. Others
      3. By Distribution Channel– Market Size & Forecast 2022-2032, USD Million
        1. Direct Tender
        2. Retail Pharmacy Chains
        3. Online Distribution Platforms
        4. Third-Party Distributors & Wholesalers
      4. By End User– Market Size & Forecast 2022-2032, USD Million
        1. Hospitals & Clinics
        2. Diagnostic Laboratories
        3. Blood Banks
        4. Point-of-Care Testing Centers
        5. Research Institutes & Academic Settings
        6. Others (e.g., mobile clinics, community health centers)
      5. By Application– Market Size & Forecast 2022-2032, USD Million
        1. Infectious Diseases
          1. Malaria 
          2. HIV/AIDS
          3. Tuberculosis
          4. Hepatitis B & C
          5. Lassa Fever
          6. Others (Diphtheria)
        2. Chronic Diseases
          1. Diabetes
          2. Cardiovascular Diseases
          3. Oncology
          4. Nephrology
          5. Others
      6. By Region
        1. North
        2. South
        3. East
        4. West
        5. Central
  12.  Nigeria Reagents & Kits In-Vitro Diagnostics (IVD) Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Share & Outlook
      1. By Technology– Market Size & Forecast 2022-2032, USD Million
      2. By Distribution Channel– Market Size & Forecast 2022-2032, USD Million
      3. By End-Users– Market Size & Forecast 2022-2032, USD Million
      4. By Application– Market Size & Forecast 2022-2032, USD Million
  13. Nigeria Instruments In-Vitro Diagnostics (IVD) Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Share & Outlook
      1. By Technology– Market Size & Forecast 2022-2032, USD Million
      2. By Distribution Channel– Market Size & Forecast 2022-2032, USD Million
      3. By End-Users– Market Size & Forecast 2022-2032, USD Million
      4. By Application– Market Size & Forecast 2022-2032, USD Million   
  14. Nigeria Consumables In-Vitro Diagnostics (IVD) Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Share & Outlook
      1. By Technology– Market Size & Forecast 2022-2032, USD Million
      2. By Distribution Channel– Market Size & Forecast 2022-2032, USD Million
      3. By End-Users– Market Size & Forecast 2022-2032, USD Million
      4. By Application– Market Size & Forecast 2022-2032, USD Million
  15. Nigeria Software & Services In-Vitro Diagnostics (IVD) Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Share & Outlook
      1. By Technology– Market Size & Forecast 2022-2032, USD Million
      2. By Distribution Channel– Market Size & Forecast 2022-2032, USD Million
      3. By End-Users– Market Size & Forecast 2022-2032, USD Million
      4. By Application– Market Size & Forecast 2022-2032, USD Million
  16. Nigeria In-Vitro Diagnostics (IVD) Market Key Strategic Imperatives for Success & Growth
  17. Competition Outlook
    1. Company Profiles
      1. Roche Diagnostics         
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Abbott Laboratories
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Siemens Healthineers
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Danaher Corporation
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Bio-Rad Laboratories
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Thermo Fisher Scientific
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Cepheid
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8.  Qiagen N.V.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Codix Pharma Ltd.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Others
  18. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now
Inquire Before Buying
Customization Offered
  • Cross-segment Market Size & Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics & Share
  • Import Export & Production Analysis
Request Customization
Related Reports